Technical Analysis for IKT - Inhibikase Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | Down |
Historical IKT trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | -2.70% | |
Hot IPO Pullback | Bullish Swing Setup | -8.43% | |
Narrow Range Bar | Range Contraction | -8.43% | |
Hot IPO Pullback | Bullish Swing Setup | -8.43% | |
NR7 | Range Contraction | -8.43% | |
Inside Day | Range Contraction | -8.43% | |
Bearish Engulfing | Bearish | -6.30% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Down 5% | 2 days ago | |
Down 3% | 2 days ago | |
Fell Below Previous Day's Low | 2 days ago | |
60 Minute Opening Range Breakdown | 2 days ago | |
Down 2 % | 2 days ago |
Get a Trading Assistant
- Earnings date: ???
Inhibikase Therapeutics, Inc. Description
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of Parkinson's Disease, dysphagia, and neurogenic constipation; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects. Its research phase products comprise IkT-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body; and IkT-148x series of portfolio compounds for use in the treatment of Dementia with Lewy Body and Multiple System Atrophy. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords:
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.8 |
52 Week Low | 6.42 |
Average Volume | 370,501 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 0.00 |
10-Day Moving Average | 7.22 |
Average True Range | 0.98 |
ADX | 0.0 |
+DI | 6.87 |
-DI | 23.94 |
Chandelier Exit (Long, 3 ATRs ) | 8.87 |
Chandelier Exit (Short, 3 ATRs ) | 9.35 |
Upper Bollinger Band | 0.00 |
Lower Bollinger Band | 0.00 |
Percent B (%b) | 0.0 |
BandWidth | 0.00 |
MACD Line | -0.20 |
MACD Signal Line | -0.08 |
MACD Histogram | -0.1173 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.54 | ||||
Resistance 3 (R3) | 7.54 | 7.31 | 7.42 | ||
Resistance 2 (R2) | 7.31 | 7.14 | 7.31 | 7.38 | |
Resistance 1 (R1) | 7.08 | 7.03 | 6.96 | 7.07 | 7.34 |
Pivot Point | 6.85 | 6.85 | 6.79 | 6.85 | 6.85 |
Support 1 (S1) | 6.61 | 6.67 | 6.50 | 6.61 | 6.34 |
Support 2 (S2) | 6.38 | 6.56 | 6.38 | 6.30 | |
Support 3 (S3) | 6.15 | 6.38 | 6.26 | ||
Support 4 (S4) | 6.14 |